SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001140361-21-002606
Filing Date
2021-01-29
Accepted
2021-01-29 09:27:31
Documents
6

Document Format Files

Seq Description Document Type Size
1 DEFM14A nc10018681x4_defm14a.htm DEFM14A 2468211
2 logo_pwp.jpg GRAPHIC 22584
3 nc10018681x4_pc01.jpg GRAPHIC 602249
4 nc10018681x4_pc02.jpg GRAPHIC 849791
5 nc10018681x4_pc03.jpg GRAPHIC 706882
6 nc10018681x4_pc04.jpg GRAPHIC 730535
  Complete submission text file 0001140361-21-002606.txt   6478425
Mailing Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ
Business Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ 44 01235 442780
Oxford Immunotec Global PLC (Filer) CIK: 0001586049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-36200 | Film No.: 21568451
SIC: 2835 In Vitro & In Vivo Diagnostic Substances